课题基金 / 基金详情

Isotopically Labeled Heparan Sulfate Glycosaminoglycan Disaccharides for use as Internal Standards

Isotopically Labeled Heparan Sulfate Glycosaminoglycan Disaccharides for use as Internal Standards
用作内标的同位素标记硫酸乙酰肝素糖胺聚糖二糖
批准号:
10080563
负责人:
RON ORLANDO
金额:
$25.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2022-08-31

项目摘要

项目成果

RON ORLANDO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Sulfated glycosaminoglycan (GAG) carbohydrates represent one of the more structurally diverse groups of biomolecules, and a comprehensive understanding of their biological structure-function relationships has yet to be achieved. Unlike other biomolecules such as DNA/RNA and proteins that are synthesized based upon a template, GAG biosynthesis is the result of the cumulative actions of a series of enzymes to produce a dynamic, polydisperse mixture. The composition of this mixture is dependent on factors such as organism age, developmental or disease state and tissue of origin. Although this diversity presents a daunting analytical challenge, significant progress has been made in the field through attempts to isolate and characterize GAGs ranging from intact polysaccharides to enzymatically prepared oligosaccharides and disaccharides. The most widespread approach is to profile GAG disaccharides via separation (HPLC, UHPLC, HILIC, CE) and detection (UV, fluorescence, mass spectrometry (MS)). Domains can be characterized for structure- function studies by combining these techniques into hyphenated methods (e.g., LC-MS). Even though disaccharide analysis is the most widely utilized method for GAG analysis, there are no readily available sources of internal standards for MS-based quantitation. Recently, multiple reaction monitoring (MRM) has been increasingly applied to GAG analysis and internal standards would significantly enhance the quantitative nature of such approaches. We propose to leverage the biosynthetic machinery of CHO-S cells, which are widely employed in the production of protein pharmaceuticals and are known to produce GAGs, as a means to generate GAGs containing stable isotopes, currently named isoGAGs. Our approach will utilize 13C6 D-glucose and an in vivo method to introduce 15N into the UDP-sugar intermediates that form the backbone of the GAG chain. As these are stable isotopes, they do not add any safety concerns. Initial efforts will be focused on the creation of a series of heparan sulfate (HS) disaccharides that we envision as a commercially available library for quantitation during disaccharide profiling experiments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CREATING ANTIBODIES TO ENABLE THE STUDY OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS IN GUINEA PIGS
  • 批准号:
    10027950
  • 项目类别:
  • 资助金额:
    $65.32万
  • 财政年份:
    2019
  • 负责人:
    RON ORLANDO
  • 依托单位:
Generation of antibodies to monitor Notch O-fucosylation in vivo
  • 批准号:
    9200115
  • 项目类别:
  • 资助金额:
    $24.23万
  • 财政年份:
    2016
  • 负责人:
    RON ORLANDO
  • 依托单位:
Development of Isotopically Labeled Glycoproteins for use as Internal Standards
  • 批准号:
    9908593
  • 项目类别:
  • 资助金额:
    $35.26万
  • 财政年份:
    2015
  • 负责人:
    RON ORLANDO
  • 依托单位:
Development of Isotopically Labeled Glycoproteins for use as Internal Standards
  • 批准号:
    8834650
  • 项目类别:
  • 资助金额:
    $27.03万
  • 财政年份:
    2015
  • 负责人:
    RON ORLANDO
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: